BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30952731)

  • 1. Effect of Stem Cell Transplant on Survival in Adult Patients With Acute Lymphoblastic Leukemia: NCDB Analysis.
    Master S; Koshy N; Mansour R; Shi R
    Anticancer Res; 2019 Apr; 39(4):1899-1906. PubMed ID: 30952731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database.
    Master S; Munker R; Shi Z; Mills G; Shi R
    Anticancer Res; 2016 Sep; 36(9):4915-21. PubMed ID: 27630349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.
    Hocking J; Schwarer AP; Gasiorowski R; Patil S; Avery S; Gibson J; Iland H; Ho PJ; Joshua D; Muirhead J; Lai H; Irving I
    Leuk Lymphoma; 2014 Dec; 55(12):2801-7. PubMed ID: 24528220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
    Chiaretti S; Vitale A; Vignetti M; Piciocchi A; Fazi P; Elia L; Falini B; Ronco F; Ferrara F; De Fabritiis P; Luppi M; La Nasa G; Tedeschi A; Califano C; Fanin R; Dore F; Mandelli F; Meloni G; Foà R
    Haematologica; 2016 Dec; 101(12):1544-1552. PubMed ID: 27515250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.
    Yoshimura T; Nakane T; Hirose A; Koh H; Nakamae M; Aimoto M; Nishimoto M; Hayashi Y; Terada Y; Nakamae H; Hino M
    Osaka City Med J; 2013 Jun; 59(1):9-21. PubMed ID: 23909077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.
    Jabo B; Morgan JW; Martinez ME; Ghamsary M; Wieduwilt MJ
    PLoS One; 2017; 12(4):e0174760. PubMed ID: 28384176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute lymphoblastic leukemia in adolescents and young adults].
    Hayakawa F
    Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
    Le Blanc K; Ringdén O; Remberger M
    Haematologica; 2003 Sep; 88(9):1044-52. PubMed ID: 12969813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
    Pavlů J; Labopin M; Zoellner AK; Sakellari I; Stelljes M; Finke J; Fanin R; Stuhler G; Afanasyev BV; Bloor AJ; Anagnostopoulos A; Mohty M; Giebel S; Nagler A
    Cancer; 2017 Jun; 123(11):1965-1970. PubMed ID: 28211939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective Analysis of the Impact of Treatment on Prognosis in 44 Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia].
    Chen XP; Lv N; Li YH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):14-8. PubMed ID: 26913386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia.
    Rotz SJ; Wei W; Thomas SM; Hanna R
    Cancer; 2020 Dec; 126(24):5319-5327. PubMed ID: 32910494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Survival in Acute Myeloid Leukemia by Treatment Modality.
    Master S; Mansour R; Devarakonda SS; Shi Z; Mills G; Shi R
    Anticancer Res; 2016 Apr; 36(4):1719-27. PubMed ID: 27069151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia in adolescents and young adults.
    Rytting ME; Jabbour EJ; O'Brien SM; Kantarjian HM
    Cancer; 2017 Jul; 123(13):2398-2403. PubMed ID: 28328172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
    Spyridonidis A; Labopin M; Schmid C; Volin L; Yakoub-Agha I; Stadler M; Milpied N; Socie G; Browne P; Lenhoff S; Sanz MA; Aljurf M; Mohty M; Rocha V;
    Leukemia; 2012 Jun; 26(6):1211-7. PubMed ID: 22290066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.